top of page

Overview

Critical Innovations is currently developing multiple medical devices toward regulatory clearance. The company focuses on task-shifting evidence-based interventions to earlier echelons of care and more general specialty levels, to simplify management and allow for rapid provision in emergency and combat environments. To date, the company has worked under more than 20 different Department of Defense awards from all three military branches charged with medical technology development (i.e. U.S. Army, Air Force, and Navy), including such agencies as the Air Force Medical Support Agency; Army Medical Research and Development Command; Defense Health Agency; and, Office of Naval Research. Contract types have included Small Business Innovation Research (SBIR), Joint Warfighter, and Other Transactional Authority. As a prime contractor, Critical Innovations currently has a 100% transition rate from Phase I to Phase II, as well as Phase II to Phase III, for all eligible SBIR programs.

Our Devices

Critical Innovations
- Jul 22, 2022
- 1 min read

Successful porcine safety trial of the F.O.A.M.™ device published in Military Medicine

Severe intra-abdominal bleeding currently requires operative treatment by trained surgeons, while Critical Innovations' patented F.O.A.M.™ technology task-shifts to allow earlier abdominal hemostasis by a wider range of providers. A recent article in Military Medicine evaluated the characteristics, survival, and histological analysis of using the F.O.A.M.™ device in a porcine model. In the study, F.O.A.M.™ reached the desired intra-abdominal pressure endpoint while not significantly altering basic hematologic parameters. These results provide strong support for the safety of the FOAM™ device and will support the design of further regulatory studies in swine and humans. See full article here.

Successful porcine safety trial of the F.O.A.M.™ device published in Military Medicine

Recent Posts